Advances in the use of angiogenesis inhibitors in cancer

Cancer J. 2001 Nov-Dec:7 Suppl 3:S107-8.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Endothelial Growth Factors / antagonists & inhibitors
  • Endothelial Growth Factors / metabolism
  • Enzyme Inhibitors / therapeutic use*
  • Fibroblast Growth Factors / metabolism
  • Humans
  • Indoles / therapeutic use
  • Lymphokines / antagonists & inhibitors
  • Lymphokines / metabolism
  • Neoplasms / blood supply
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neovascularization, Pathologic / prevention & control*
  • Oxindoles
  • Platelet-Derived Growth Factor / metabolism
  • Propionates
  • Pyrroles / therapeutic use
  • Receptors, Growth Factor / antagonists & inhibitors
  • Transforming Growth Factors / metabolism
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Endothelial Growth Factors
  • Enzyme Inhibitors
  • Indoles
  • Lymphokines
  • Oxindoles
  • Platelet-Derived Growth Factor
  • Propionates
  • Pyrroles
  • Receptors, Growth Factor
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Fibroblast Growth Factors
  • Semaxinib
  • Transforming Growth Factors
  • orantinib